Health
CureVac starts clinical trial for COVID-19 vaccine candidate – Reuters India
German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
By Reuters Staff
FILE PHOTO: A vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac is ready to use at the start of a clinical test series in the tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
BERLIN (Reuters) -German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
The trial, which is relevant for regulatory…
-
General24 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News21 hours agoFatal Traffic Crash, South Bingera
-
General23 hours agoBathurst 1000 quick hits: Chaz Mostert drinks beer with fans, Erebus owner protests, and drama on Mount Panorama
-
Noosa News17 hours agoTrucking company penalised for refusing to pay unfairly sacked worker